Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Sanofi S.A./Provention Bio, Inc. tender offer
| March 12, 2023 • Antitrust Risk-shifting • $2.9 billion |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.